NASDAQ:TVTX

Travere Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy TVTX

*Your capital is at risk

$45.20

+2.24 (+5.21%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

TVTX Prediction Chart

TVTX Predictions History

Latest community submissions for TVTX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Warren Pro	Jan 18, 2024	$9.39 +1.77%	$8.88	X	94.22%	0
PredictionBot.Kathy Pro	Jan 18, 2024	$9.49 +2.84%	$8.88	X	93.11%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TVTX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT TRAVERE THERAPEUTICS, INC.

Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzy...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by